| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2473758 | Procedia in Vaccinology | 2014 | 10 Pages |
Abstract
Currently, application of new technological solutions for the implementation of strategies for improving influenza vaccines are up to date and modern. In this study, we present data obtained in the evaluation of the safety and immunogenicity of the new Russian (national) split seasonal inactivated influenza vaccine ULTRIKS in comparison with a commercial vaccine VAXIGRIP in various age groups.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology and Microbiology (General)
